Dr Christophe Willekens
- Spécialité
- Hématologue, expert myélome et leucémie
- Hôpital
- Gustave Roussy (Villejuif)
- Derniers articles
-
- Circulating Proteins Associated with Anti-IL6 Receptor Therapeutic Resistance in the Sera of Patients with Severe COVID-19. (1 oct. 2024)
- Relevance, Risks, and Benefits of Early-Phases Clinical Trials Participations for Patients With Hematological Malignancies From 2008 to 2023. (21 sept. 2024)
- RAS mutations in myeloid malignancies: revisiting old questions with novel insights and therapeutic perspectives. (24 avr. 2024)
- Correction: Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers. (14 févr. 2024)
- When monoclonal gammopathy-associated chronic neutrophilic leukemia is a reactive process distinct from a clonal myeloproliferative neoplasm: Lessons from mistakes. (19 mai 2023)